Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IL-13 receptor-alpha2: a novel target for cancer therapy.

× No keyword cloud information.

12 in total

1. Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer.

Authors: Andrea Formentini; Philipp Braun; Harald Fricke; Karl-Heinrich Link; Doris Henne-Bruns; Marko Kornmann
Journal: Int J Colorectal Dis Date: 2012-03-24 Impact factor: 2.571

2. Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13.

Authors: Wu Ou; Michael P Marino; Akiko Suzuki; Bharat Joshi; Syed R Husain; Andrea Maisner; Evanthia Galanis; Raj K Puri; Jakob Reiser
Journal: Hum Gene Ther Methods Date: 2012-05-21 Impact factor: 2.396

Review 3. Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies.

Authors: L A Marr; D E Gilham; J D M Campbell; A R Fraser
Journal: Clin Exp Immunol Date: 2012-02 Impact factor: 4.330

Review 4. Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer.

Authors: Dennis J Yoon; Christina T Liu; Devin S Quinlan; Parsa M Nafisi; Daniel T Kamei
Journal: Ann Biomed Eng Date: 2011-02-25 Impact factor: 3.934

5. IL-13 receptor α2 stimulates human glioma cell growth and metastasis through the Src/PI3K/Akt/mTOR signaling pathway.

Authors: Ming Tu; Wei Wange; Lin Cai; Penglei Zhu; Zhichao Gao; Weiming Zheng
Journal: Tumour Biol Date: 2016-09-14

6. IL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.

Authors: Z Zhao; L Wang; W Xu
Journal: Oncogene Date: 2014-04-21 Impact factor: 9.867

7. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.

Authors: Jing Han; Raj K Puri
Journal: J Neurooncol Date: 2017-11-22 Impact factor: 4.130

IL-13 receptor-alpha2: a novel target for cancer therapy.